DHR · 10-Q · 2026Q2 · Full report

Life Sciences Demand Trends

DANAHER CORP /DE/ · 2026-07-21 · Importance 49 · Surprise 32 · No source text

Life Sciences sales increased 5.5% in the second quarter and 4.5% in the first half of 2026, driven primarily by consumables and secondarily by equipment demand. Applied, pharmaceutical, biopharmaceutical and biotechnology customer demand continued to strengthen, while academic and government demand improved modestly but remained muted. High-growth markets led geographic growth in both periods. Filtration growth was driven by higher demand for microelectronic and energy products; instruments growth included flow cytometry, lab automation and mass spectrometry consumables, with microscopy and mass spectrometry equipment demand improving in the quarter but equipment demand lower year to date.

Key facts

• Life Sciences segment sales for the three-month period ended June 26, 2026 were $1,879 million and $1,777 million for the comparable period in 2025. source
• Life Sciences segment sales for the six-month period ended June 26, 2026 were $3,616 million and $3,457 million for the comparable period in 2025. source
• Life Sciences core sales growth (non-GAAP) was 5.5% for the three-month period ended June 26, 2026 and 3.0% for the six-month period ended June 26, 2026. source
• Life Sciences reported that demand from applied, pharmaceutical, biopharmaceutical and biotechnology customers continued to strengthen in the first half of 2026 and demand from academic and government customers improved modestly but remained muted overall. source

Impact estimates